South Korea’s Constitutional Court strikes down law banning anti-Pyongyang leafleting

0
SEOUL, South Korea (AP) — South Korea’s Constitutional Court on Tuesday struck down a 2020 law that criminalized the sending of anti-Pyongyang propaganda leaflets...

UN says cholera and dengue outbreaks have been reported in eastern Sudan as conflict...

0
CAIRO (AP) — Outbreaks of cholera and dengue fever have been reported in eastern Sudan, where thousands of people are sheltering in crowded camps...

2 explosions rip through dwellings in Sweden. At least one is reportedly connected to...

0
STOCKHOLM (AP) — Two powerful explosions have ripped through dwellings in central Sweden, injuring at least three people and damaging buildings, with bricks and...

China goes on charm offensive at Asian Games, but doesn’t back down from regional...

0
HANGZHOU, China (AP) — A month before the Asian Games, China released a new national map, doubling down on its claims to almost the...

India and US army chiefs call for free and stable Indo-Pacific as Chinese influence...

0
NEW DELHI (AP) — India's army chief on Tuesday said the country was committed to maintaining a free and stable Indo-Pacific, where the sovereignty...

At least 20 dead in gas station explosion as Nagorno-Karabakh residents flee to Armenia

0
YEREVAN, Armenia (AP) — Separatist authorities in Nagorno-Karabakh said Tuesday that at least 20 people were killed and nearly 300 others injured by an...

Researchers have verified 1,329 hunger deaths in Ethiopia’s Tigray region since the cease-fire there

0
NAIROBI, Kenya (AP) — Researchers say they have verified 1,329 deaths from hunger in Ethiopia’s northern Tigray region since a cease-fire ended a two-year...

Stock market today: Wall Street points lower on interest rate reality, looming US shutdown

0
Wall Street is poised to open lower ahead of a possible U.S. government shutdown and as the realization sets in that interest rates may...

After US approval, Japan OKs its first Alzheimer’s drug. Leqembi was developed by Eisai...

0
TOKYO (AP) — Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies....

After US approval, Japan OKs its first Alzheimer’s drug. Leqembi was developed by Eisai...

0
TOKYO (AP) — Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies....